Pfizer Recalls Four Anti-Bacterial Injections in India

Pfizer

Pfizer, a leading pharmaceutical company, has recalled four anti-bacterial injections manufactured by Astral SteriTech Pvt Ltd in India. The recall was initiated after an “out-of-specification” deviation was observed during routine environmental monitoring at Astral SteriTech’s manufacturing block.

The four injections that were recalled are:

  • Ceftriaxone
  • Cefotaxime
  • Gentamicin
  • Tobramycin

These injections are used to treat a variety of bacterial infections, including pneumonia, sepsis, and urinary tract infections.

Pfizer has stated that the recall is a precautionary measure and that there is no evidence that the injections are unsafe. However, the company is recalling the injections to ensure the safety of its patients.

Pfizer has advised patients who have been prescribed any of the recalled injections to contact their healthcare provider. Patients who have already received the injections are not at risk and do not need to take any further action.

Pfizer has apologized for any inconvenience the recall may cause and has assured patients that the company is committed to the safety and quality of its products.

The recall is a reminder of the importance of pharmaceutical companies taking steps to ensure the safety of their products. It is also a reminder to patients to be aware of recalls and to contact their healthcare provider if they have any questions or concerns.